drostanolone enanthate

Intramuscular administration of recommended doses, the drug is rapidly absorbed and distributed in organs and tissues via endolymphatic transportation way; It has a high affinity for bodies of the hematopoietic system; He has been actively involved in cellular metabolism, embedding into cell structures. During drostanolone enanthate the course of daily use of the property has cumulated in organs and tissues. The time to reach maximum concentration in single introduction – 0.5 hours, and then start reducing the concentration of drug in the blood associated with its distribution in the organs and tissues. Repeated intraperitoneal injection every 24 hours for 4 days, the highest observed its accumulation in the spleen, lymph nodes and bone marrow. After the 5th injection drug concentration subsequent introductions in all organs and tissues does not increase, there has been a gradual decline.

Metabolism and excretion of
drug is excreted from the body (in the form of metabolites), partly with feces and more – urine. The average retention time of the drug in tissues and organs – 72 hours. Half-time – 36 hours.

Indications
Ferrovir used in combination therapy for HIV-infected patients and AIDS patients, HIV-infected patients with hepatitis C, HIV-infected patients with recurrent herpes infection. When treating patients with tick-borne encephalitis, hepatitis C, herpes.

Contraindications
Individual intolerance.

Pregnancy and lactation, children’s age.

Dosage and administration
in the treatment of HIV infection or drostanolone enanthate, adult drug administered intramuscularly: 5 ml (15 mg / ml) solution for intramuscular administration (75 mg, based on dry substance), 2 times a day (150 mg) for 14 days . If necessary, after 1-1.5 months reappointed therapy.

In the treatment of herpes – 5 ml (15 mg / ml) solution for intramuscular injection 2 times a day, for 10 days.

In the treatment of hepatitis  administered intramuscularly 2 times a day by 5 mL (15 mg / ml) solution for intramuscular injection for 14 days. In the next 14 days the drug is administered at the same daily dose every other day.

Tick-borne encephalitis when the drug is administered two times daily for 5 ml (15 mg / ml) solution for intramuscular injection for 5-10 days.

When using intramuscular solution 2ml produce recalculated until course dose 750 – 2100 mg.

Side effect
Perhaps a transient increase in body temperature (up to 38 ° C), redness and mild pain at the injection site.

Overdose
negative phenomena have been identified from an overdose.

Interaction with other drugs
moderately potentiates the effect of anticoagulants.

In the treatment reduces the toxicity and adverse effects of the drugs (headache, nausea, etc.)

Cautions
To reduce morbidity  administered intramuscularly slowly for 1-2 minutes.

The solution for injection should be drostanolone enanthate fully used immediately after opening the bottle, do not store open bottles.

Intravenous administration of the drug is not allowed!

Product form
The solution for intramuscular injection of 15 mg / ml in 2 ml vials of 5 ml of neutral or dark glass.

Original packaging 5 vials of 5 ml or 10 vials of 2 ml in the pan-blister with instruction in a cardboard drostanolone enanthate box.